Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable

Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable

User Photo
Annual-Meeting

2 years
131 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Nghiem, MD, PhD, University of Washington, explains Avelumab, for Metastatic Merkel Cell Carcinoma | Observed Responses are Durable at Annual Meeting 2018
Up Next Autoplay